These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7961566)

  • 21. Brain region effects of clozapine on amino acid and monoamine transmission.
    Yamamoto BK; Pehek EA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():8-14. PubMed ID: 7961581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of repeated administration of clozapine and haloperidol on the effects of the activation of 5-HT(1A), 5-HT(2) and 5-HT(4) receptors in rat frontal cortex.
    Zahorodna A; Bobula B; Grzegorzewska M; Tokarski K; Hess G
    J Physiol Pharmacol; 2004 Jun; 55(2):371-9. PubMed ID: 15213359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors.
    Squires RF; Saederup E
    Neurochem Res; 1999 May; 24(5):659-67. PubMed ID: 10344595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin and psychiatric disorders. A key to new therapeutic approaches.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1992 Feb; 42(2A):246-9. PubMed ID: 1586395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
    Schwieler L; Engberg G; Erhardt S
    Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different receptor subtypes are involved in the serotonin-induced modulation of epileptiform activity in rat frontal cortex in vitro.
    Bobula B; Zahorodna A; Bijak M
    J Physiol Pharmacol; 2001 Jun; 52(2):265-74. PubMed ID: 11453105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
    Paul D; Yao D; Zhu P; Minor LD; Garcia MM
    J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system.
    Kilpatrick GJ; Hagan RM; Gale JD
    Behav Brain Res; 1996; 73(1-2):11-3. PubMed ID: 8788470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat.
    Watling KJ; Beer MS; Stanton JA; Newberry NR
    Eur J Pharmacol; 1990 Jul; 182(3):465-72. PubMed ID: 1977590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine produces potent antidopaminergic effects anatomically specific to the mesolimbic system.
    Gardner EL; Chen J; Paredes W
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():15-22. PubMed ID: 7961561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems.
    Tricklebank MD
    Behav Brain Res; 1996; 73(1-2):15-7. PubMed ID: 8788471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of central and peripheral serotonin-reactive structures on the cardiovascular system and respiration].
    Pastukhov VA
    Fiziol Zh SSSR Im I M Sechenova; 1983 Dec; 69(12):1569-74. PubMed ID: 6607182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of 5-HT3 receptors in drug dependence.
    Grant KA
    Drug Alcohol Depend; 1995 May; 38(2):155-71. PubMed ID: 7671767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a domain which affects kinetics and antagonistic potency of clozapine at 5-HT3 receptors.
    Rammes G; Hosp C; Eisensamer B; Tanasic S; Nothdurfter C; Zieglgänsberger W; Rupprecht R
    PLoS One; 2009 Aug; 4(8):e6715. PubMed ID: 19696922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limbic selectivity of clozapine.
    Longhurst J
    Lancet; 1997 Nov; 350(9088):1399-400. PubMed ID: 9365474
    [No Abstract]   [Full Text] [Related]  

  • 40. Atypical antipsychotics--serotonergic mechanisms but don't forget dopamine.
    Vile JM; Strange PG
    J Psychopharmacol; 1997; 11(1):24-5. PubMed ID: 9097888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.